Streetbeat News

Equity Actions

ULTA

Ulta Beauty's stock is trading lower following the announcement of Q4 financial results and FY24 revenue guidance that fell short of expectations. Additionally, the company's board has approved a new $2.0 billion share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 12:28 pm

DCTH

Delcath Systems has announced a $7 million private placement to raise funds. This financial move could indicate the company's strategy for growth or operational expansion, potentially impacting its stock price.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 12:27 pm

CISS

C3is Inc. has announced the pricing of a $6M underwritten public offering. This move is aimed at raising capital, potentially for expansion, debt reduction, or other corporate purposes. The offering could dilute current shareholders but also provides the company with necessary funds for growth or operational improvements.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 12:25 pm

GMAB

Genmab has announced the initiation of a DKK3.5 billion share buy-back program, aiming to return value to shareholders and potentially improve earnings per share by reducing the number of shares outstanding.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 12:19 pm

MSTR

MicroStrategy Incorporated (NASDAQ:MSTR) announced the pricing of its offering of $525 million 0.875% convertible senior notes due 2031, upsized from $500 million. The offering, aimed at qualified institutional buyers, includes an option for an additional $78.75 million in notes and is expected to close on March 18, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 12:08 pm

PATH

Analyst ratings for UiPath (NYSE:PATH) have varied over the last quarter, with a recent positive shift in sentiment. The average 12-month price target has risen by 14.6% to $26.93. Recent analyst actions include upgrades in ratings and price targets by several firms, reflecting an optimistic outlook on the company's performance. UiPath has shown a solid revenue growth rate of 24.05% as of October 31, 2023, but struggles with profitability and efficiency, as indicated by its below-industry-average net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 12:02 pm

CPE

Analysts have a neutral outlook on Callon Petroleum (NYSE:CPE), with all four recent ratings being indifferent. The 12-month price target averages $36.25, down from $40.67, indicating a 10.87% decrease. Analysts from Mizuho and Stifel have adjusted their price targets and ratings, reflecting concerns over Callon's financial performance, including a -14.61% revenue decline, below-average net margin, ROE, and ROA, but a healthier debt-to-equity ratio compared to the industry.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 12:01 pm

BRLT

Brilliant Earth Group (NASDAQ:BRLT) has been analyzed by 4 analysts, showing a mix of bullish and indifferent sentiments. The average 12-month price target is $3.6, up from $3.45, with targets ranging from $3.00 to $4.00. Analyst actions include maintaining and lowering ratings, reflecting changing market dynamics and company performance. Brilliant Earth Group, known for ethically-sourced jewelry, shows strong financial health with notable revenue growth, net margin, ROE, and ROA, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 12:00 pm

XELB

Xcel Brands announced the pricing of a $2.42 million public offering of common stock, alongside a concurrent private placement. This move aims to raise capital, potentially for expansion or operational purposes.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 11:57 am

PANL

Pangaea Logistics Solutions has announced the renewal of its shelf registration statement, allowing the company to issue new securities in the future. This strategic move provides Pangaea with flexibility in financing options and growth opportunities.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 11:33 am